| Bioactivity | SARS-CoV-2 3CLpro-IN-22 (Compound 17) is a cathepsin L (CTSL ) inhibitor with an IC50 value of 32.5 nM. SARS-CoV-2 3CLpro-IN-22 can be used for the study of SARS-CoV-2 virus[1]. |
| Target | IC50: 32.5 nM (cathepsin). |
| Name | SARS-CoV-2 3CLpro-IN-22 |
| Formula | C22H23ClN4O3 |
| Molar Mass | 426.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ciaglia T, et al. Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization[J]. European Journal of Medicinal Chemistry, 2024: 116128. |